p53 downstream target genes and tumor suppression: a classical view in evolution

被引：99

作者：

Rozan, L. M.

El-Deiry, W. S.

机构：

[1] Univ Penn, Sch Med, Lab Mol Oncol & Cell Cycle Regulat, Dept Med Hematol Oncol, Philadelphia, PA 19104 USA

[2] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA

[3] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA

[4] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Abramson Comprehens Canc Ctr, Philadelphia, PA 19104 USA

来源：

CELL DEATH AND DIFFERENTIATION | 2007年 / 14卷 / 01期

关键词：

D O I：

10.1038/sj.cdd.4402058

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：3 / 9

页数：7

共 98 条

[1] TIGAR, a p53-inducible regulator of glycolysis and apoptosis [J].

Bensaad, Karim ;

Tsuruta, Atsushi ;

Selak, Mary A. ;

Calvo Vidal, M. Nieves ;

Nakano, Katsunori ;

Bartrons, Ramon ;

Gottlieb, Eyal ;

Vousden, Karen H. .

CELL, 2006, 126 (01) :107-120

[2] ASPP1 and ASPP2: Common activators of p53 family members [J].

Bergamaschi, D ;

Samuels, Y ;

Jin, BQ ;

Duraisingham, S ;

Crook, T ;

Lu, X .

MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (03) :1341-1350

[3] p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis [J].

Bergamaschi, D ;

Gasco, M ;

Hiller, L ;

Sullivan, A ;

Syed, N ;

Trigiante, G ;

Yulug, I ;

Merlano, M ;

Numico, G ;

Comino, A ;

Attard, M ;

Reelfs, O ;

Gusterson, B ;

Bell, AK ;

Heath, V ;

Tavassoli, M ;

Farrell, PJ ;

Smith, P ;

Lu, X ;

Crook, T .

CANCER CELL, 2003, 3 (04) :387-402

[4] iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human [J].

Bergamaschi, D ;

Samuels, Y ;

O'Neil, NJ ;

Trigiante, G ;

Crook, T ;

Hsieh, JK ;

O'Connor, DJ ;

Zhong, S ;

Campargue, I ;

Tomlinson, ML ;

Kuwabara, PE ;

Lu, X .

NATURE GENETICS, 2003, 33 (02) :162-167

[5] Mutations in proline 82 of p53 impair its activation by Pin1 and Chk2 in response to DNA damage [J].

Berger, M ;

Stahl, N ;

Del Sal, G ;

Haupt, Y .

MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (13) :5380-5388

[6] A large-scale RNAi screen in human cells identifies new components of the p53 pathway [J].

Berns, K ;

Hijmans, EM ;

Mullenders, J ;

Brummelkamp, TR ;

Velds, A ;

Heimerikx, M ;

Kerkhoven, RM ;

Madiredjo, M ;

Nijkamp, W ;

Weigelt, B ;

Agami, R ;

Ge, W ;

Cavet, G ;

Linsley, PS ;

Beijersbergen, RL ;

Bernards, R .

NATURE, 2004, 428 (6981) :431-437

[7] Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23 [J].

Bertwistle, D ;

Sugimoto, M ;

Sherr, CJ .

MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (03) :985-996

[8] Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression [J].

Bossi, G ;

Lapi, E ;

Strano, S ;

Rinaldo, C ;

Blandino, G ;

Sacchi, A .

ONCOGENE, 2006, 25 (02) :304-309

[9] p53 isoforms can regulate p53 transcriptional activity [J].

Bourdon, JC ;

Fernandes, K ;

Murray-Zmijewski, F ;

Liu, G ;

Diot, A ;

Xirodimas, DP ;

Saville, MK ;

Lane, DP .

GENES & DEVELOPMENT, 2005, 19 (18) :2122-2137

[10] INDUCTION OF THE GROWTH INHIBITOR IGF-BINDING PROTEIN-3 BY P53 [J].

BUCKBINDER, L ;

TALBOTT, R ;

VELASCOMIGUEL, S ;

TAKENAKA, I ;

FAHA, B ;

SEIZINGER, BR ;

KLEY, N .

NATURE, 1995, 377 (6550) :646-649

← 1 2 3 4 5 6 7 8 9 10 →